KIR2DL3 Antikörper (Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3)

Details for Product anti-KIR2DL3 Antibody No. ABIN2478646
Antigen
  • CD158B2
  • CD158b
  • GL183
  • KIR-023GB
  • KIR-K7b
  • KIR-K7c
  • KIRCL23
  • NKAT
  • NKAT2
  • NKAT2A
  • NKAT2B
  • p58
  • killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 3
  • KIR2DL3
Reaktivität
Human
90
3
1
Wirt
Maus
63
27
Klonalität (Klon)
Monoklonal ()
Konjugat
Dieser KIR2DL3 Antikörper ist unkonjugiert
7
6
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
Applikation
Flow Cytometry (FACS), Western Blotting (WB)
50
30
23
15
13
11
6
5
3
2
2
1
1
Optionen
Immunogen Recombinant human KIR2DL3
Klon 190IIC311
Isotyp IgG2a
Produktmerkmale Purified IgG
Reinigung Purified
Plasmids, Primers & others Plasmide, Primers & weitere KIR2DL3 products on genomics-online (e.g. as negative or positive controls)
Antigen
Andere Bezeichnung CD158b (KIR2DL3 Antibody Abstract)
Hintergrund Synonyms: KIR2DL3
Gen-ID 3804
UniProt P43628
Pathways Cancer Immune Checkpoints
Applikations-hinweise Optimal working dilution should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1.0 mg/mL
Bilder des Herstellers
Image no. 1 for anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) antibody (ABIN2478646) anti-Killer Cell Immunoglobulin-Like Receptor, Two Domains, Long Cytoplasmic Tail, 3 (KIR2DL3) antibody
Produkt verwendet in: Shin, Shin, Kim, Choi, Park, Kim: "Monoclonal antibodies with various reactivity to p58 killer inhibitory receptors." in: Hybridoma, Vol. 18, Issue 6, pp. 521-7, 2000 (PubMed).

Haben Sie etwas anderes gesucht?